Shreyas Kalantri/X
Aug 4, 2025, 14:54
Shreyas Kalantri: Engaging Insights on VTE Management
Shreyas Kalantri, Hematology and Oncology Chief Fellow at UofL Brown Cancer Center, shares an insight on VTE management on X:
”VTE management doesn’t stop at anticoagulation. Here are pearls to sharpen your heme boards prep and clinical instincts.
1. Thrombus extension after starting anticoagulation ≠ treatment failure.
Asymptomatic progression can happen in the first 1–2 weeks. No need to escalate therapy unless clinically indicated.”
Dr. Shreyas Kalantri offers engaging and thought‑provoking insights to help you refine and master your clinical reasoning—well worth following.
Stay tuned with Hemostasis Today.
-
Aug 14, 2026, 23:18Claire Hills: New Paper on Immune Surveillance and Immune Evasion of Senescent Cells
-
Aug 14, 2026, 23:16Are We Overlooking What Matters Most to Women with Von Willebrand Disease? – RPTH Journal
-
Aug 14, 2026, 23:15Markus Müller: A New Base Editing Approach Targeting PCSK9 to Lower Cholesterol Levels
-
Aug 14, 2026, 23:14Chokri Ben Lamine: Avatrombopag in Hematology – Dosing and Monitoring
-
Aug 14, 2026, 23:13Bianca Rocca: PRECISE-DAPT Score Identifies Bleeding Risk After CABG in Patients With POAF
-
Aug 14, 2026, 19:04Ravi Kumar: Why Lupus Anticoagulant Predicts Clots, Not Bleeding
-
Aug 14, 2026, 18:53Veli Bakalov: The Number Every Hematologist Should Know in Polycythemia Vera
-
Aug 14, 2026, 18:41Marta Velia Antonini: Can Nitric Oxide Protect the ECMO Circuit Without Systemic Anticoagulation?
-
Aug 14, 2026, 18:30Irina Gontschar: What the Epkinly FDA Review Teaches Us About Sponsor Oversight